关注
david favor
david favor
未知所在单位机构
在 antarespharma.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Azide and cyanide displacements via hypervalent silicate intermediates
ED Soli, AS Manoso, MC Patterson, P DeShong, DA Favor, R Hirschmann, ...
The Journal of Organic Chemistry 64 (9), 3171-3177, 1999
2071999
Total synthesis of (+)-azaspiracid-1. An exhibition of the intricacies of complex molecule synthesis
DA Evans, L Kværnø, TB Dunn, A Beauchemin, B Raymer, JA Mulder, ...
Journal of the American Chemical Society 130 (48), 16295-16309, 2008
1202008
Total Synthesis of (+)‐Azaspiracid‐1. Part II: Synthesis of the EFGHI Sulfone and Completion of the Synthesis
DA Evans, TB Dunn, L Kværnø, A Beauchemin, B Raymer, EJ Olhava, ...
Angewandte Chemie 119 (25), 4782-4787, 2007
692007
Chemically diverse group I p21-activated kinase (PAK) inhibitors impart acute cardiovascular toxicity with a narrow therapeutic window
J Rudolph, LJ Murray, CO Ndubaku, T O’Brien, E Blackwood, W Wang, ...
Journal of medicinal chemistry 59 (11), 5520-5541, 2016
672016
[1, 8] naphthyridin-2-ones and related compounds for the treatment of schizophrenia
DS Johnson, JT Repine, AD White
US Patent 7,160,888, 2007
642007
Molecular modeling, synthesis, and structures of N-methylated 3, 5-linked pyrrolin-4-ones toward the creation of a privileged nonpeptide scaffold
AB Smith III, DA Favor, PA Sprengeler, MC Guzman, PJ Carroll, GT Furst, ...
Bioorganic & medicinal chemistry 7 (1), 9-22, 1999
551999
A second-generation synthesis of scalemic 3, 5, 5-trisubstituted pyrrolin-4-ones: Incorporation of functionalized amino acid side-chains
AB Smith III, AB Benowitz, DA Favor, PA Sprengeler, R Hirschmann
Tetrahedron letters 38 (22), 3809-3812, 1997
391997
Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder
DS Johnson, C Choi, LK Fay, DA Favor, JT Repine, AD White, HC Akunne, ...
Bioorganic & medicinal chemistry letters 21 (9), 2621-2625, 2011
382011
Synthesis of polypyrrolinones on solid support
AB Smith, H Liu, H Okumura, DA Favor, R Hirschmann
Organic Letters 2 (14), 2041-2044, 2000
322000
Pyrrolo [2, 1-f][1, 2, 4] triazines: from C-nucleosides to kinases and back again, the remarkable journey of a versatile nitrogen heterocycle
GR Ott, DA Favor
Bioorganic & Medicinal Chemistry Letters 27 (18), 4238-4246, 2017
302017
Synthesis of monofluorinated 1-(naphthalen-1-yl) piperazines
JT Repine, DS Johnson, AD White, DA Favor, MA Stier, J Yip, T Rankin, ...
Tetrahedron letters 48 (31), 5539-5541, 2007
282007
Synthesis of methyl-, fluoro-, and chloro-substituted 6-hydroxyisoindolin-1-ones
JJ Powers, DA Favor, T Rankin, R Sharma, C Pandit, A Jeganathan, ...
Tetrahedron Letters 50 (12), 1267-1269, 2009
222009
6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics
DA Favor, JJ Powers, AD White, LW Fitzgerald, V Groppi, KA Serpa
Bioorganic & medicinal chemistry letters 20 (19), 5666-5669, 2010
182010
Synthesis of chromanyl and dihydrobenzofuranyl piperazines
DA Favor, DS Johnson, JJ Powers, T Li, R Madabattula
Tetrahedron Letters 48 (17), 3039-3041, 2007
182007
Sulfonamides as selective oestrogen receptor β agonists
LR Roberts, D Armor, C Barker, A Bent, K Bess, A Brown, DA Favor, ...
Bioorganic & medicinal chemistry letters 21 (19), 5680-5683, 2011
152011
Naphthyridines as inhibitors of HPK1
B Chan, N Rajapaksa, M Siu, C Stivala, J Tellis, W Wang, BQ Wei, A Zhou, ...
US Patent 10,407,424, 2019
102019
Serendipity in drug-discovery: a new series of 2-(benzyloxy) benzamides as TRPM8 antagonists
A Brown, D Ellis, DA Favor, T Kirkup, W Klute, M MacKenny, G McMurray, ...
Bioorganic & medicinal chemistry letters 23 (22), 6118-6122, 2013
102013
Isoquinolines as inhibitors of HPK1
B Chan, J Drobnick, L Gazzard, T Heffron, J Liang, S Malhotra, ...
US Patent 11,566,003, 2023
62023
Isoquinolines as inhibitors of hpk1
B Chan, J Drobnick, L Gazzard, T Heffron, J Liang, S Malhotra, ...
62022
Oxazolidinones and methods for the synthesis and use of same
AB Smith III, RF Hirschmann, PA Sprengeler, AB Benowitz, DA Favor
US Patent 6,034,247, 2000
52000
系统目前无法执行此操作,请稍后再试。
文章 1–20